nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—ABCB1—ovarian cancer	0.389	1	CbGaD
Ranitidine—ABCB1—Topotecan—ovarian cancer	0.0605	0.148	CbGbCtD
Ranitidine—CYP3A5—Paclitaxel—ovarian cancer	0.046	0.113	CbGbCtD
Ranitidine—ABCB1—Vinorelbine—ovarian cancer	0.0426	0.105	CbGbCtD
Ranitidine—CYP2D6—Vinorelbine—ovarian cancer	0.0402	0.0985	CbGbCtD
Ranitidine—CYP3A4—Topotecan—ovarian cancer	0.0362	0.0889	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—ovarian cancer	0.0333	0.0816	CbGbCtD
Ranitidine—ABCB1—Paclitaxel—ovarian cancer	0.0299	0.0734	CbGbCtD
Ranitidine—CYP3A4—Vinorelbine—ovarian cancer	0.0255	0.0626	CbGbCtD
Ranitidine—ABCB1—Docetaxel—ovarian cancer	0.0217	0.0531	CbGbCtD
Ranitidine—CYP3A4—Paclitaxel—ovarian cancer	0.0179	0.044	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—ovarian cancer	0.0161	0.0396	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—ovarian cancer	0.0152	0.0373	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—ovarian cancer	0.013	0.0318	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—ovarian cancer	0.00967	0.0237	CbGbCtD
Ranitidine—Nizatidine—ABCB1—ovarian cancer	0.00448	1	CrCbGaD
Ranitidine—Angina pectoris—Docetaxel—ovarian cancer	0.000469	0.00236	CcSEcCtD
Ranitidine—Tachycardia—Vinorelbine—ovarian cancer	0.000469	0.00236	CcSEcCtD
Ranitidine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000465	0.00233	CcSEcCtD
Ranitidine—Bradycardia—Paclitaxel—ovarian cancer	0.000463	0.00233	CcSEcCtD
Ranitidine—Feeling abnormal—Topotecan—ovarian cancer	0.000463	0.00232	CcSEcCtD
Ranitidine—Pancytopenia—Docetaxel—ovarian cancer	0.000457	0.0023	CcSEcCtD
Ranitidine—Neutropenia—Docetaxel—ovarian cancer	0.00045	0.00226	CcSEcCtD
Ranitidine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00045	0.00226	CcSEcCtD
Ranitidine—Hypotension—Vinorelbine—ovarian cancer	0.000449	0.00225	CcSEcCtD
Ranitidine—Pruritus—Chlorambucil—ovarian cancer	0.000446	0.00224	CcSEcCtD
Ranitidine—Urticaria—Topotecan—ovarian cancer	0.000446	0.00224	CcSEcCtD
Ranitidine—Body temperature increased—Topotecan—ovarian cancer	0.000444	0.00223	CcSEcCtD
Ranitidine—Abdominal pain—Topotecan—ovarian cancer	0.000444	0.00223	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000438	0.0022	CcSEcCtD
Ranitidine—Urticaria—Melphalan—ovarian cancer	0.000437	0.00219	CcSEcCtD
Ranitidine—Weight decreased—Docetaxel—ovarian cancer	0.000436	0.00219	CcSEcCtD
Ranitidine—Pneumonia—Docetaxel—ovarian cancer	0.000432	0.00217	CcSEcCtD
Ranitidine—Diarrhoea—Chlorambucil—ovarian cancer	0.000432	0.00217	CcSEcCtD
Ranitidine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00043	0.00216	CcSEcCtD
Ranitidine—Dyspnoea—Vinorelbine—ovarian cancer	0.000428	0.00215	CcSEcCtD
Ranitidine—Photosensitivity—Epirubicin—ovarian cancer	0.000428	0.00215	CcSEcCtD
Ranitidine—Jaundice—Docetaxel—ovarian cancer	0.000419	0.0021	CcSEcCtD
Ranitidine—Hepatic failure—Epirubicin—ovarian cancer	0.000418	0.0021	CcSEcCtD
Ranitidine—Hypersensitivity—Topotecan—ovarian cancer	0.000414	0.00208	CcSEcCtD
Ranitidine—Constipation—Vinorelbine—ovarian cancer	0.000411	0.00206	CcSEcCtD
Ranitidine—Pain—Vinorelbine—ovarian cancer	0.000411	0.00206	CcSEcCtD
Ranitidine—Arrhythmia—Paclitaxel—ovarian cancer	0.000406	0.00204	CcSEcCtD
Ranitidine—Hypersensitivity—Melphalan—ovarian cancer	0.000405	0.00203	CcSEcCtD
Ranitidine—Alopecia—Paclitaxel—ovarian cancer	0.000402	0.00202	CcSEcCtD
Ranitidine—Vomiting—Chlorambucil—ovarian cancer	0.000401	0.00201	CcSEcCtD
Ranitidine—Agranulocytosis—Docetaxel—ovarian cancer	0.000401	0.00201	CcSEcCtD
Ranitidine—Pruritus—Topotecan—ovarian cancer	0.000397	0.002	CcSEcCtD
Ranitidine—Photosensitivity—Doxorubicin—ovarian cancer	0.000396	0.00199	CcSEcCtD
Ranitidine—Erythema—Paclitaxel—ovarian cancer	0.000396	0.00199	CcSEcCtD
Ranitidine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000396	0.00199	CcSEcCtD
Ranitidine—Pruritus—Melphalan—ovarian cancer	0.000389	0.00195	CcSEcCtD
Ranitidine—Hepatic failure—Doxorubicin—ovarian cancer	0.000387	0.00194	CcSEcCtD
Ranitidine—Hepatitis—Docetaxel—ovarian cancer	0.000385	0.00194	CcSEcCtD
Ranitidine—Diarrhoea—Topotecan—ovarian cancer	0.000384	0.00193	CcSEcCtD
Ranitidine—Urticaria—Vinorelbine—ovarian cancer	0.000382	0.00192	CcSEcCtD
Ranitidine—Body temperature increased—Vinorelbine—ovarian cancer	0.00038	0.00191	CcSEcCtD
Ranitidine—Abdominal pain—Vinorelbine—ovarian cancer	0.00038	0.00191	CcSEcCtD
Ranitidine—Diarrhoea—Melphalan—ovarian cancer	0.000376	0.00189	CcSEcCtD
Ranitidine—Nausea—Chlorambucil—ovarian cancer	0.000375	0.00188	CcSEcCtD
Ranitidine—Vision blurred—Paclitaxel—ovarian cancer	0.000373	0.00187	CcSEcCtD
Ranitidine—Dizziness—Topotecan—ovarian cancer	0.000371	0.00187	CcSEcCtD
Ranitidine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000367	0.00185	CcSEcCtD
Ranitidine—Anaemia—Paclitaxel—ovarian cancer	0.000366	0.00184	CcSEcCtD
Ranitidine—Erythema multiforme—Docetaxel—ovarian cancer	0.000364	0.00183	CcSEcCtD
Ranitidine—Agitation—Paclitaxel—ovarian cancer	0.000364	0.00183	CcSEcCtD
Ranitidine—Angioedema—Paclitaxel—ovarian cancer	0.000362	0.00182	CcSEcCtD
Ranitidine—Cardiac arrest—Epirubicin—ovarian cancer	0.000357	0.0018	CcSEcCtD
Ranitidine—Vomiting—Topotecan—ovarian cancer	0.000357	0.00179	CcSEcCtD
Ranitidine—Malaise—Paclitaxel—ovarian cancer	0.000357	0.00179	CcSEcCtD
Ranitidine—Vertigo—Paclitaxel—ovarian cancer	0.000356	0.00179	CcSEcCtD
Ranitidine—Leukopenia—Paclitaxel—ovarian cancer	0.000354	0.00178	CcSEcCtD
Ranitidine—Rash—Topotecan—ovarian cancer	0.000354	0.00178	CcSEcCtD
Ranitidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000354	0.00178	CcSEcCtD
Ranitidine—Dermatitis—Topotecan—ovarian cancer	0.000354	0.00178	CcSEcCtD
Ranitidine—Blood creatinine increased—Epirubicin—ovarian cancer	0.000352	0.00177	CcSEcCtD
Ranitidine—Headache—Topotecan—ovarian cancer	0.000352	0.00177	CcSEcCtD
Ranitidine—Vomiting—Melphalan—ovarian cancer	0.00035	0.00176	CcSEcCtD
Ranitidine—Rash—Melphalan—ovarian cancer	0.000347	0.00174	CcSEcCtD
Ranitidine—Dermatitis—Melphalan—ovarian cancer	0.000346	0.00174	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—ovarian cancer	0.000344	0.00173	CcSEcCtD
Ranitidine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000343	0.00172	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—ovarian cancer	0.000341	0.00171	CcSEcCtD
Ranitidine—Pruritus—Vinorelbine—ovarian cancer	0.00034	0.00171	CcSEcCtD
Ranitidine—Breast disorder—Epirubicin—ovarian cancer	0.00034	0.00171	CcSEcCtD
Ranitidine—Chest pain—Paclitaxel—ovarian cancer	0.000337	0.00169	CcSEcCtD
Ranitidine—Arthralgia—Paclitaxel—ovarian cancer	0.000337	0.00169	CcSEcCtD
Ranitidine—Myalgia—Paclitaxel—ovarian cancer	0.000337	0.00169	CcSEcCtD
Ranitidine—Erythema—Docetaxel—ovarian cancer	0.000336	0.00169	CcSEcCtD
Ranitidine—Nausea—Topotecan—ovarian cancer	0.000334	0.00168	CcSEcCtD
Ranitidine—Discomfort—Paclitaxel—ovarian cancer	0.000333	0.00167	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000331	0.00167	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000331	0.00166	CcSEcCtD
Ranitidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000329	0.00165	CcSEcCtD
Ranitidine—Nausea—Melphalan—ovarian cancer	0.000327	0.00164	CcSEcCtD
Ranitidine—Confusional state—Paclitaxel—ovarian cancer	0.000326	0.00164	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000326	0.00164	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—ovarian cancer	0.000325	0.00163	CcSEcCtD
Ranitidine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000323	0.00162	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—ovarian cancer	0.000322	0.00162	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—ovarian cancer	0.000318	0.0016	CcSEcCtD
Ranitidine—Dizziness—Vinorelbine—ovarian cancer	0.000318	0.0016	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000318	0.0016	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—ovarian cancer	0.000316	0.00159	CcSEcCtD
Ranitidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000316	0.00159	CcSEcCtD
Ranitidine—Tachycardia—Paclitaxel—ovarian cancer	0.000315	0.00158	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—ovarian cancer	0.000314	0.00158	CcSEcCtD
Ranitidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000312	0.00157	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—ovarian cancer	0.00031	0.00156	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—ovarian cancer	0.000309	0.00155	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000307	0.00154	CcSEcCtD
Ranitidine—Vomiting—Vinorelbine—ovarian cancer	0.000305	0.00153	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—ovarian cancer	0.000304	0.00153	CcSEcCtD
Ranitidine—Rash—Vinorelbine—ovarian cancer	0.000303	0.00152	CcSEcCtD
Ranitidine—Dermatitis—Vinorelbine—ovarian cancer	0.000303	0.00152	CcSEcCtD
Ranitidine—Hypotension—Paclitaxel—ovarian cancer	0.000302	0.00152	CcSEcCtD
Ranitidine—Headache—Vinorelbine—ovarian cancer	0.000301	0.00151	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—ovarian cancer	0.000301	0.00151	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—ovarian cancer	0.0003	0.00151	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—ovarian cancer	0.000298	0.00149	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000297	0.00149	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—ovarian cancer	0.000295	0.00148	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000294	0.00148	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—ovarian cancer	0.000294	0.00148	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—ovarian cancer	0.000293	0.00147	CcSEcCtD
Ranitidine—Insomnia—Paclitaxel—ovarian cancer	0.000292	0.00147	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—ovarian cancer	0.000291	0.00146	CcSEcCtD
Ranitidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000288	0.00145	CcSEcCtD
Ranitidine—Somnolence—Paclitaxel—ovarian cancer	0.000287	0.00144	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—ovarian cancer	0.000286	0.00144	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—ovarian cancer	0.000286	0.00144	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—ovarian cancer	0.000286	0.00144	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—ovarian cancer	0.000285	0.00143	CcSEcCtD
Ranitidine—Nausea—Vinorelbine—ovarian cancer	0.000285	0.00143	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—ovarian cancer	0.000282	0.00142	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—ovarian cancer	0.000281	0.00141	CcSEcCtD
Ranitidine—Sweating—Epirubicin—ovarian cancer	0.000278	0.00139	CcSEcCtD
Ranitidine—Pain—Paclitaxel—ovarian cancer	0.000276	0.00139	CcSEcCtD
Ranitidine—Constipation—Paclitaxel—ovarian cancer	0.000276	0.00139	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—ovarian cancer	0.000276	0.00139	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000274	0.00138	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000274	0.00138	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—ovarian cancer	0.000272	0.00137	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—ovarian cancer	0.00027	0.00136	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—ovarian cancer	0.00027	0.00135	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000268	0.00135	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—ovarian cancer	0.000267	0.00134	CcSEcCtD
Ranitidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000266	0.00134	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—ovarian cancer	0.000265	0.00133	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—ovarian cancer	0.000261	0.00131	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—ovarian cancer	0.00026	0.00131	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—ovarian cancer	0.000257	0.00129	CcSEcCtD
Ranitidine—Urticaria—Paclitaxel—ovarian cancer	0.000257	0.00129	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—ovarian cancer	0.000256	0.00129	CcSEcCtD
Ranitidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000255	0.00128	CcSEcCtD
Ranitidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000255	0.00128	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00025	0.00126	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00025	0.00125	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—ovarian cancer	0.000248	0.00124	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000246	0.00123	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—ovarian cancer	0.000245	0.00123	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—ovarian cancer	0.000244	0.00123	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—ovarian cancer	0.000243	0.00122	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—ovarian cancer	0.000241	0.00121	CcSEcCtD
Ranitidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000238	0.0012	CcSEcCtD
Ranitidine—Pain—Docetaxel—ovarian cancer	0.000234	0.00118	CcSEcCtD
Ranitidine—Constipation—Docetaxel—ovarian cancer	0.000234	0.00118	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—ovarian cancer	0.000232	0.00117	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—ovarian cancer	0.00023	0.00115	CcSEcCtD
Ranitidine—Pruritus—Paclitaxel—ovarian cancer	0.000229	0.00115	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000227	0.00114	CcSEcCtD
Ranitidine—Erythema—Epirubicin—ovarian cancer	0.000226	0.00114	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000226	0.00113	CcSEcCtD
Ranitidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000221	0.00111	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—ovarian cancer	0.000217	0.00109	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—ovarian cancer	0.000217	0.00109	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—ovarian cancer	0.000215	0.00108	CcSEcCtD
Ranitidine—Dizziness—Paclitaxel—ovarian cancer	0.000214	0.00107	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—ovarian cancer	0.000213	0.00107	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—ovarian cancer	0.000213	0.00107	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00021	0.00105	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—ovarian cancer	0.000209	0.00105	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—ovarian cancer	0.000209	0.00105	CcSEcCtD
Ranitidine—Agitation—Epirubicin—ovarian cancer	0.000208	0.00104	CcSEcCtD
Ranitidine—Vomiting—Paclitaxel—ovarian cancer	0.000205	0.00103	CcSEcCtD
Ranitidine—Malaise—Epirubicin—ovarian cancer	0.000204	0.00103	CcSEcCtD
Ranitidine—Rash—Paclitaxel—ovarian cancer	0.000204	0.00102	CcSEcCtD
Ranitidine—Dermatitis—Paclitaxel—ovarian cancer	0.000204	0.00102	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—ovarian cancer	0.000203	0.00102	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—ovarian cancer	0.000203	0.00102	CcSEcCtD
Ranitidine—Headache—Paclitaxel—ovarian cancer	0.000202	0.00102	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000202	0.00101	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—ovarian cancer	0.000197	0.000991	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000194	0.000976	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—ovarian cancer	0.000194	0.000973	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—ovarian cancer	0.000194	0.000972	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—ovarian cancer	0.000193	0.000968	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—ovarian cancer	0.000193	0.000968	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—ovarian cancer	0.000193	0.000968	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—ovarian cancer	0.000192	0.000967	CcSEcCtD
Ranitidine—Nausea—Paclitaxel—ovarian cancer	0.000192	0.000964	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—ovarian cancer	0.00019	0.000956	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—ovarian cancer	0.000189	0.000949	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—ovarian cancer	0.000188	0.000945	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—ovarian cancer	0.000187	0.000942	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—ovarian cancer	0.000187	0.000941	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—ovarian cancer	0.000186	0.000936	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000185	0.000928	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—ovarian cancer	0.000181	0.00091	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000181	0.000908	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—ovarian cancer	0.00018	0.000906	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000179	0.000897	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—ovarian cancer	0.000178	0.000896	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—ovarian cancer	0.000178	0.000896	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—ovarian cancer	0.000178	0.000896	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—ovarian cancer	0.000176	0.000885	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—ovarian cancer	0.000174	0.000875	CcSEcCtD
Ranitidine—Rash—Docetaxel—ovarian cancer	0.000173	0.000867	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—ovarian cancer	0.000173	0.000867	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—ovarian cancer	0.000173	0.000867	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—ovarian cancer	0.000172	0.000866	CcSEcCtD
Ranitidine—Headache—Docetaxel—ovarian cancer	0.000172	0.000862	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000171	0.000859	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000168	0.000845	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000167	0.000841	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—ovarian cancer	0.000167	0.000839	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—ovarian cancer	0.000167	0.000838	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000165	0.00083	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—ovarian cancer	0.000165	0.000827	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—ovarian cancer	0.000164	0.000825	CcSEcCtD
Ranitidine—Nausea—Docetaxel—ovarian cancer	0.000163	0.000817	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—ovarian cancer	0.00016	0.000802	CcSEcCtD
Ranitidine—Constipation—Epirubicin—ovarian cancer	0.000158	0.000793	CcSEcCtD
Ranitidine—Pain—Epirubicin—ovarian cancer	0.000158	0.000793	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000156	0.000782	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—ovarian cancer	0.000155	0.000777	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—ovarian cancer	0.000152	0.000765	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000152	0.000765	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—ovarian cancer	0.000152	0.000763	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—ovarian cancer	0.000147	0.000737	CcSEcCtD
Ranitidine—Pain—Doxorubicin—ovarian cancer	0.000146	0.000734	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—ovarian cancer	0.000146	0.000734	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—ovarian cancer	0.000146	0.000734	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—ovarian cancer	0.000146	0.000734	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000141	0.000707	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000136	0.000684	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—ovarian cancer	0.000136	0.000682	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000135	0.000679	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—ovarian cancer	0.000135	0.000679	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—ovarian cancer	0.000131	0.000656	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—ovarian cancer	0.000126	0.000635	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000126	0.000633	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—ovarian cancer	0.000122	0.000614	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—ovarian cancer	0.000121	0.000607	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—ovarian cancer	0.000117	0.00059	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—ovarian cancer	0.000117	0.000587	CcSEcCtD
Ranitidine—Rash—Epirubicin—ovarian cancer	0.000116	0.000585	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—ovarian cancer	0.000116	0.000585	CcSEcCtD
Ranitidine—Headache—Epirubicin—ovarian cancer	0.000116	0.000581	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—ovarian cancer	0.000113	0.000568	CcSEcCtD
Ranitidine—Nausea—Epirubicin—ovarian cancer	0.00011	0.000551	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—ovarian cancer	0.000109	0.000546	CcSEcCtD
Ranitidine—Rash—Doxorubicin—ovarian cancer	0.000108	0.000541	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—ovarian cancer	0.000108	0.000541	CcSEcCtD
Ranitidine—Headache—Doxorubicin—ovarian cancer	0.000107	0.000538	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—ovarian cancer	0.000102	0.00051	CcSEcCtD
